Diabetes Research Centre publications

Professor Len Harrison, Professor Peter Colman, Associate Professor John Wentworth

Recent original research papers

Wentworth JM, Dalziel KM, O'Brien PE, Burton P, Shaba F, Clarke PM, Laiteerapong N, Brown WA (2017) Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S. J Diabetes Complications Jul 31. doi: 10.1016/j.jdiacomp.2017.04.009

Hendrieckx C, Poole LA, Sharifi A. Jayawardene D, Loh MM, Horsburgh JC, Bach LA, Colman PG, Kumareswaran K, Jenkins AJ, MacIsaac RJ, Ward GM, Grosman B,  Anirban Roy A, O’Neal DN, Speight J. It is definitely a game changer’: a qualitative study of experiences with in-home overnight closed-loop technology among adults with type 1 diabetes.  Diabetes Technology and Therapeutics. July 2017, 19(7): 410-416

Mariño E, Richards JL, McLeod KH, Yap YA, Stanley D, Kranich J, McKenzie C, Oliveira AC, Mason L, Rossello FJ, Balasubramanian Krishnamurthy, Nefzger C, Macia L, Thorburn A, Baxter AG, Morahan G, Wong L, Polo JM, Moore RJ, Lockett TJ, Clarke JM, Topping DL, Harrison LC, Mackay CR (2017) Gut microbial metabolites limit autoimmune T cell frequencies and protect against type 1 diabetes. Nature Immunology doi: 10.1038/ni.3713.

Augstein P, Loudovaris T, Bandala-Sanchez E, Heinke P, Naselli G, Lee L, Hawthorne WJ, Rogers K, Góñez LJ, Neale AM, Vaillant F, Thomas HE, Kay TW, Banakh I, Harrison LC (2017). The human pancreas side population as a reservoir of adult stem cells. Pancreas (in press).

Rashidi M, Bandala-Sanchez E, Lawlor KE, Zhang Y, Neale AM, LekhaVijayaraj S, O'Donoghue R, Adams TE, Wentworth JM, Vince JE, Harrison LC (2017). CD52 inhibits Toll-like Receptor activation of NF-kB and triggers apoptosis to suppress inflammation. Cell Death Diff  (in press).

Steck AK, Xu P, Geyer S, Redondo MJ, Antinozzi P, Wentworth JM, Sosenko J, Onengut-Gumuscu S, Chen WM, Rich SS, Pugliese A, Type 1 Diabetes TrialNet Study Group (2017). Can non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab May 17. doi:10.1210/jc.2016-4003.

Wentworth JM, Burton P, Laurie C, Brown WA, O'Brien PE (2017). Five-Year Outcomes of a Randomized Trial of Gastric Band Surgery in Overweight but Not Obese People With Type 2 Diabetes. Diabetes Care Apr. doi: 10.2337/dc16-2149.

Ooi GJ, Doyle L, Tie T, Wentworth JM, Laurie C, Earnest A, Cowley MA, Sikaris K, le Roux CW, Burton PR, O'Brien PE, Brown WA (2017). Weight loss after laparoscopicadjustable gastric band and resolution of the metabolic syndrome and its components. Int J Obes (Lond). Mar 21. doi: 10.1038/ijo.2017.59.

Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, O'Brien PE, Brown WA (2017). Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. Obes Surg. Jan 27. doi: 10.1007/s11695-016-2246-5.

Wentworth JM, Zhang J-G, Bandala-Sanchez E, Naselli G, Liu C, Ritchie M, Smyth GK, O’Brien PE, Harrison LC (2016). Interferon-gamma secreted from omental adipose tissue of insulin-resistant humans impairs adipocyte morphology and function. Int J Obesity (in press, 2017). 

Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, Earnest A, O'Brien PE, Brown WA (2016). Effects of bariatric surgery on liver function tests in patients with nonalcoholic fatty liver disease. Obes Surg. Dec 13. doi: 10.1007/s11695-016-2482-8.

Pattison DA, Hofman MS, Bazargan A, Colman PG, Hicks RJ (2016).  Intense focal pituitary FDG uptake due to Intravascular Large B-cell lymphoma in pyrexia of unknown origin. American Journal of Hematology  doi: 10.1002/ajh.24469.

Clapin H, Phelan H, Bruns L Jn, Sinnott R, Colman PG, Craig M, Jones T (2016).  Australian Diabetes Data Network: Building a collaborative resource.  J Diab Sci Technol.  doi: https://doi.org/10.1177/1932296816648983

Zhang Y, Feng Z-P, Naselli G, Bell F, Wettenhall J, Auyeung P, Speed TP, Chong MW, Harrison LC (2016) MicroRNAs in CD4+ T cell subsets are markers of disease risk and T cell dysfunction in individuals at risk for T1D. J Autoimmunity Apr doi: 10.1016/j.jaut.2015.12.006

Mathieu C, Zinman B, Udden Hemmingsson J, Woo V, Colman PG, Christiansen E, Linder M, Bode B for Adjunct One Investigators (2016) Efficacy and safety of Liraglutide added to insulin treatment in type 1 diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.  Diabetes Care doi: 10.2337/dc16-0691


Pugliese A, Boulware D, Yu L, Babu S, Steck AK, Becker D, Rodriguez H, DiMeglio L, Evans-Molina C, Harrison LC, Schatz D, Palmer JP, Greenbaum C, Eisenbarth GS, Sosenko JM and the T1D TrialNet Study Group (2016) The HLA-DRB1*15:01, DQA1*01:02-B1*06:02 haplotype protects autoantibody-positive relatives from T1D throughout the stages of disease progression. Diabetes doi: 10.2337/db15-1105

Zhang Y, Collier F, Naselli G, Saffery R, Tang ML, Allan KJ, Ponsonby A-L, Harrison LC (co-senior author), Vuillermin P, on behalf of the BIS Investigator Group (2016) Cord blood monocyte-derived inflammatory cytokines suppress IL-2 and induce non-classic ‘Th2-type’ immunity associated with development of food allergy. Science Trans Med 8: 321ra8, doi: 10.1126/scitranslmed.aad4322.


​Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, O'Brien PE, Brown WA (2016) Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. Obes Surg May 24. doi: 10.1007/s11695-016-2246-5

Yadgar-Yalda R, Fourlanos S, Colman PG, Wentworth JM (2016) Factors associated with insulin-induced weight gain in an Australian type 2 diabetes outpatient clinic. Internal Medicine Journal Jul. doi: 10.1111/imj.13122.


O’Brien PE, DeWitt DE, Laurie C, Brenan L, Wentworth JM, Anderson M, O’Dea K, Dean F, Smith A, Dalton DP (2016) The effect of weight loss on indigenous Australians with diabetes: A study of Feasibility, Acceptability and Effectiveness of Laparoscopic Adjustable Gastric Banding. Obesity Surgery Jan. doi: 10.1007/s11695-015-1733-4.


Murphy AJ, Kraakman MJ, Kammoun HL, Dragoljevic D, Lee MKS, Lawlor KE, Wentworth JM, Vasanthakumar A, Gerlic M, Whitehead LW, DiRago L, Cengia L, Lane RM, Metcalf D, Vince JE, Harrison LC, Kallies A, Kile BT, Croker BA, Febbraio MA, Masters SL (2016) IL-18 Production from the NLRP1 inflammasome prevents obesity and metabolic syndrome. Cell Metab Jan 12. doi: 10.1016/j.cmet.2015.09.024

Bonifacio E, Mathieu C, Nepom G, Ziegler A-G, Anhalt H, Haller M, Harrison LC, Hebrok M, Kuschner J, Norris JM, Peakman M, Powers AC, Todd JA, Atkinson M (2016) Rebranding type 1 diabetes: the case for autoimmune beta cell disorder as a pathologic and diagnostic entity. A consensus statement from the type 1 diabetes Iceland Summit. Diabetologia doi: 10.1007/s00125-016-4144-8

Zeigler A-G, Bonifacio E, Powers AC, Todd JA, Harrison LC, Atkinson M (2016) Type 1 diabetes prevention-a goal dependent on accepting a diagnosis of asymptomatic disease. Diabetes doi: 10.2337/db16-0687

Sharifi A, DeBock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach L, Colman PG, Davis EA, Grosman B, Hendrieckx C, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Speight J, Trawley S, Ward GM, Roy A, Jones TW, O’Neal DN (2016) Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: A randomized crossover study. Diabetes Technology and Therapeutics doi: 10.1089/dia.2016.0288


Wentworth JM, Naselli G, Ngui K, Smyth GK, Liu R, O'Brien PE, Bruce C, Weir J, Cinel M, Meikle PJ, Harrison LC (2015). GM3 ganglioside and phosphatidylethanolamine-containing lipids are adipose tissue markers of insulin resistance in obese women. International Journal of Obesity Oct 26. doi: 10.1038/ijo.2015.223.

Phillips J, Couper JJ, Penno M, Harrison LC and the ENDIA Study Group (2016) Type 1 diabetes: a disease of developmental origins. Ped Diabetes Aug 15. doi: 10.1111/pedi.12425.

Brady JL, Harrison LC, Goodman DJ, Cowan PJ, Hawthorne WJ, O'Connell PJ, Sutherland RM, Lew AM (2015) Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a huSCID model. Clin Translat Immunol doi: 10.1038/cti.2014.28.


Jiang F-X, Mishina Y, Baten A, Morahan G, Harrison LC (2015) Transcriptome of pancreas-specific Bmpr1a-deleted islets links to TPH1-5-HT axis. Biology Open 4: 1016-23.


Augstein P, Naselli G, Loudovaris T, Hawthorne WJ, Campbell P, Bandala-Sanchez E, Rogers K, Heinke P, Thomas HE, Kay TW, Harrison LC (2015) Localisation of dipeptidyl peptidase-4 (CD26) to human pancreatic ducts and islet alpha cells. Diab Res Clin Pract 110:291-300.


Andrew J Murphy, Michael J Kraakman, Helene L. Kammoun1,3, Dragana Dragoljevich1,3, Man K. S. Lee1,3,Kate E. Lawlor, John M Wentworth, Ajithkumar Vasanthakumar, Motti Gerlic, Ladina DiRago, Louise Cengia, Rachael M. Lane7,9, Donald Metcalf, Andrew W Roberts, James E Vince, Leonard C Harrison, Axel Kallies, Benjamin T Kile, Ben A Croker, Mark A Febbraio, Seth L Masters (2015) IL-18 production from the NLRP1 inflammasome prevents obesity and metabolic syndrome. Cell Metabolism 23:155-164.


Wentworth JM, Naselli G, Ngui K, Smyth GK, Liu R, O’Brien PE, Bruce C, Weir J, Cinel M, Meikle PJ, Harrison LC (2015) GM3 ganglioside and phosphatidylethanolamine-containing lipids are adipose tissue markers of insulin resistance in obese women. Int J Obesity doi: 10.1038/ijo.2015.223.

Xu S, Alexander K, Bryant W, Cohen N, Craig M, Forbes M, Fulcher G, Greenaway T, Harrison N, Holmes-Walker J, Howard G, Jackson J, Jenkins A, Kamp M, Kaye J, Sinha A, Stranks S, O’Neal D, Colman PG (2015). Healthcare Professional Requirements for the care of diabetes patients managed with insulin pumps in Australia. Int Med. J 45:86-93.

Wentworth JM, Playfair J, Laurie C, Brown WA, Burton P, Shaw JE, O’Brien PE (2015). Gastric band surgery leads to improved insulin secretion in overweight people with type 2 diabetes. Obesity Surgery  25(12):2400-7.


Vasanthakumar A, Moro K, Xin A, Liao Y, Gloury R, Kawamoto S, Fagarasan S, Mielke LA, Afshar-Sterle S, Masters SL, Nakae S, Saito H, Wentworth JM, Li P, Liao W, Leonard WJ, Smyth GK, Shi W, Nutt SL, Koyasu S, Kallies A (2015). The transcriptional regulators irf4, batf and il-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nature Immunology 16:276–285

Sharifi A, Varsosky A, Ulloa J, Horsburgh JC, McAulay S, Krishnamurthy B, Jenkins AJ, Colman PG, Ward GM, MacIsaac R, Shar R, O’Neal DN (2015). Redundancy in glucose sensing: Enhanced reliability of an Electrochemical Redundant Sensor for continuous glucose monitoring. J Diabetes Technol, Oct 22, pu:1932296815612096.

Sachin A, Zaidi G, Sahu R, Agrawal S, Colman PG, Bhatia E (2015) Low prevalence of latent autoimmune diabetes in adults in North Indian patients. Diabetic Medicine 32:810-3.

Suaini NHA, Zhang Y, Vuillermin PJ, Allen KA, Harrison LC (2015) Immune modulation by vitamin D and its relevance to food allergy. Nutrients 7:6088-108.


Fourlanos S,  Elkassaby S, Varney MD, Colman PG, Harrison LC (2014) Higher body mass index in adults at diagnosis of T1D is associated with lower risk HLA genes. Diab Res Clin Pract S0168-8227(14)00128-4.


Zhang Y, Kinkel S, Maksimovic J, Bandala-Sanchez E, Tanzer MC, Naselli G, Zhang J-G, Zhan Y, Silke J, Oshlack A, Blewitt ME and Harrison LC (2014) The polycomb repressive complex 2 governs life and death of peripheral T cells. Blood 124:737-49.


Wentworth JM, Lukic V, Bahlo M, Findlay M, Nguyen C, Morahan G, Harrison LC (2014) Maturity-onset diabetes of the young type 5 (MODY5) in a family with diabetes and mild kidney disease diagnosed by whole exome sequencing. Int Med J 44:1137-40.


Elkassaby S, Harrison LC (corresponding author), Mazzitelli N, Wentworth JM, Colman PG, Spelman T, Fourlanos S (2014). A randomized controlled trial of high dose vitamin D3 in recent-onset T2D. Diab Res Clin Pract 106: 576-82.

Hendriecks C, Halliday JA, Bowden J, Colman PG, Cohen N, Jenkins A, Speight J (2014). Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Research Clinical Practice. 103 : 430-436.


Honeyman MC, Laine D, Londrigan S, Kirkwood C, Harrison LC (2014) Rotavirus infection induces transient pancreatic involution and hyperglycemia in weanling mice. PLoS One doi:10.1371/journal.pone.0106560.


Wentworth JM, Playfair J, Laurie C, Ritchie ME, Brown WA, Burton P, Shaw JE, O'Brien PE (2014). Multidisciplinary diabetes care with and without bariatric surgery in overweight people: A randomised controlled trial. The Lancet. Diabetes & Endocrinology 2:545-552.

Yates CJ, Barraclough KB, McWhinney BC, Ungerer JPJ, Fullinfaw R, Colman PG, Fourlanos S, Cohney SJ (2014). A practical limited sampling strategy to predict free prednisolone exposure and glycaemia in kidney transplant patients. Therapeutic drug monitoring 36 : 18-23.


Wentworth JM, Lukic V, Bahlo M, Finlay M, Nguyen C, Morahan G, Harrison LC (2014). Maturity-onset diabetes of the young type 5 in a family with diabetes and mild kidney disease diagnosed by whole exome sequencing. Internal Medicine Journal 44:1137-1140


Wentworth JM, Hensman T, Playfair J, Laurie C, Ritchie ME, Brown WA, Skinner S, Shaw JE, O'Brien PE (2014) Laparoscopic adjustable gastric banding and progression from impaired fasting glucose to diabetes. Diabetologia 57:463-468


Price SA, Gorelik A, Fourlanos S, Colman PG, Wentworth JM (2014). Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes. Obesity Research and Clinical Practice 8:e178-182.


Gianatti EJ, Dupuis P, Hoermann R, Strauss BJ, Wentworth JM, Zajac JD, Grossmann M (2014) Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: A randomized controlled trial. Diabetes Care 37:2098-2107


Elkassaby S, Harrison LC, Mazzitelli N, Wentworth JM, Colman PG, Spelman T, Fourlanos S (2014) A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes. Diabetes Research and Clinical Practice 106:576-582


Nguyen C, Varney MD, Harrison LC, Morahan G (2013) Definition of high-risk T1D HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms. Diabetes 62-2135-2140


Bandala-Sanchez E, Zhang Y, Reinwald S, Dromey JA, Lee B-H, Qian J, Böhmer RM, Harrison LC (2013) T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10. A novel mechanism of T cell regulation mediated by soluble CD52 and Siglec-10. Nature Immunol 14:741-748.


Cornall LM, Mathai ML, Hryciw DH, Simcocks AC, O'Brien PE, Wentworth JM, McAinch AJ (2013) GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes. Molecular and Cellular Endocrinology 365:108-118.

Brady JL, Sutherland RM, Hancock M, Kitsoulis S, Lahoud MH, Phillips P, Hawthorne WJ, d’Apice AJF, Cowan PJ, Harrison LC, O’Connell PJ, Lew AM (2013). Pig xenografts producing anti-CD2 antibody effect localized deletion of human T cells in a huSCID model. Xenotransplantation 20: 100-9.


Roep BO, Solvason N, Gottlieb PA, Abreu JRF, Harrison LC, Eisenbarth GS, Yu L, Leviten M, Hagopian WA, Buse JB, von Herrath M, Quan J, King R, Robinson WH, Utz PJ, Garren H, The BHT 3021 Investigators and Steinman L (2013). Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in T1D. Science Trans Med 5(191):191ra82.

Zhang Y, Maksimovic J, Naselli G, Qian J, Blewitt ME, Oshlack A, Harrison LC (2013). Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells. Blood 122:2823-2836.

Penno MAS, Couper JJ, Craig ME, Colman PG, Rawlinson WD, Cotterill AM, Jones TW, Harrison LC and the ENDIA Study Group (2013) Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of T1D. BMC Pediatrics 13:124 doi:10.1186/1471-2431-13-124.

Coppieters KT, Harrison LC, von Herrath MG (2013) Trials in T1D: Antigen-specific therapies. Clin Immunol 149:345-355.

Harrison LC, Wentworth JM, Zhang Y, Bandala-Sanchez E, Böhmer RM, Neale AM,Stone NL, Naselli G, Bosco JJ, Auyeung P, Rashidi M, Augstein P, Morahan G (2013) Antigen-based vaccination and prevention of T1D. Curr Diabetes Reports 13: 616-623.

Yates CJ, Fourlanos S, Colman PG, Cohney SJ (2013) Screening for New-Onset Diabetes after kidney transplantation: Limitations of Fasting Glucose and Advantages of Afternoon Glucose and Glycated Haemoglobin. Transplantation 96: 726-731

Harrison LC (2012). Insulin-specific vaccination for T1D: a step closer? Hum Vaccines Immunother 8:834-837.

Micallef SJ, Li X, Schiesser J, Hirst C, Yu QC, Lim SM, Nostro MC, Elliott DA, Sarangi F, Harrison LC, Keller G, Elefanty AG and Stanley EG (2012). Isolation and characterisation of insulin-expressing cells differentiated from INSGFP/w human embryonic stem cells. Diabetologia 55: 694-706.


Lee I, Harrison LC, Colman PG (2012). Fulminant T1D in Australia in the absence of humoral and cellular immune responses to pancreatic islet autoantigens. Diab Res Clin Prac 95: 4-6.


Xue M, Dervish S, Harrison LC, Fulcher G, CJ Jackson (2012) Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells and prevents diabetes in NOD mice. J Biol Chem 287: 16356-16364.


Banakh I, Gonez LJ, Sutherland RM, Naselli G, Harrison, LC (2012). Adult pancreas side population cells expand after β cell injury and are a source of insulin-secreting cells. PLoS One 7:e48977.     


Wentworth JM, Fourlanos S, Colman PG (2012) Body mass index correlates with ischemic heart disease and albuminuria in long-standing type 2 diabetes. Diabetes Research and Clinical Practice 97:57-62

D’Emden MC, Shaw JE, Colman PG, Colaguiri S, Twigg SM, Jones GRD, Goodall I, Schneider HG, Wah-Cheung N (2012) The role of HbA1c in the diagnosis of diabetes mellitus in Australia. MJA 197:1-3.


Temmerman L, De Livera AM, Bowne JB, Sheedy JR, Callahan DL, Nahid A, De Souza DP, Schoofs L, Tull DL, McConville MJ, Roessner U, Wentworth JM (2012) Cross-platform urine metabolomics of experimental hyperglycemia in type 2 diabetes. Journal of Diabetes and Metabolism S6-002 doi:10.4172/2155-6156.S6-002

Shelton E, Khaw D, Colman P, Fourlanos S, Marion K, Nicoll A (2012) Glycaemia does not predict liver biochemistry in fatty liver disease. J Med Res & Sci. 2:55-60.

Yates C, Fourlanos S, Hjelmesaeth J, Colman PG, Cohney S (2012). New-onset diabetes after transplantation - changes and challenges. American Journal of Transplantation doc: 12: 820-828.

Reviews, books and commentaries

Harrison LC (Feb 2018) Type 1 Diabetes. In: Rich, R.R. et al. Clinical Immunology: Principles and Practice, 5th edn. Elsevier, London UK.


Penno MA, Thomson RL, Couper JJ, ENDIA Study Group (inc. Harrison LC, Wentworth JM, Colman PC) (2016). Bunbury to Bundaberg, Darwin to Dover: establishing a successful Regional Participation Program for the ENDIA type 1 diabetes cohort study. Med J Aust 205:486.

Harrison LC (2016) Immunity: Humoral and Cellular. In: Encyclopedia of Life Sciences, John Wiley & Sons, Ltd: Chichester DOI: 10.1002/9780470015902.a0001236.pub3


Harrison LC (2016) T1D. In Clinical Immunology: Principles and Practice, 5th edition. Elsevier, Oxford UK (in press, May 1, 2016).


Kyi M, Wentworth JM, Nankervis AJ, Fourlanos S, Colman PG (2015) Recent advances in type 1 diabetes. Medical Journal of Australia 203(7):290-3.

Nguyen H, Colman PG (2015) Life expectancy in patients with type 1 diabetes – issues and challenges.  Diabetes Management Journal.  51:5-7.

Harrison LC, Wentworth JM (2014) Prevention of autoimmune disease: The type 1 diabetes paradigm. In: Mackay IR, Rose NR, eds. The Autoimmune Diseases London Elsevier 1191-1220.

Harrison LC, Wentworth JM, Zhang Y, Bandala-Sanchez E, Bohmer RM, Neale AM, Stone NL, Naselli G, Bosco JJ, Auyeung P, Rashidi M, Augstein P, Morahan G (2013) Antigen-based vaccination and prevention of type 1 diabetes. Current Diabetes Reports 13:616-623

So M, Colman PG (2013) Glycaemic variability in diabetes – the long term significance. Diabetes Management Journal. 45:18.


Harrison LC (2012) Oh my genome! What does ENCODE mean for people with diabetes? Diabetes Connect (published by the Australian Diabetes Council).


Honeyman MC, Harrison LC (2012) Rotavirus and T1D. In Diabetes and Viruses (Toniolo A, Ed). Springer, New York DOI 10.1007/978-1-4614-4051-2_18, Springer Science+Business Media New York.


Zhang Y, Bandala-Sanchez E, Harrison LC (2012) Revisiting regulatory T cells in T1D. Curr Opin Endocrinol Diabetes Obes 19: 271-278.